Should NICE evaluate complementary and alternative medicines?
Colquhoun
David
D
Department of Pharmacology, University College London, London WC1E 6BT. d.colquhoun@ucl.ac.uk
D000529:Complementary Therapies / Q000191:economics / Q000592:standards* / Q000706:statistics & numerical data; D003362:Cost-Benefit Analysis; D005069:Evaluation Studies as Topic; D006077:Government Agencies; D006801:Humans; D013222:State Medicine; D006113:United Kingdom